1-2 of 2
Florian Grebien, PhD
Close
Sort by
Journal Articles

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Emir Hadzijusufovic, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD PhD, Wilfried Schgoer, MD PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Wolfgang R Sperr, MD, Uwe Rix, PhD, Irina Sadovnik, MSc, Bernd Jilma, MD, Gerit Holger Schernthaner, MD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent, MD
Journal: Blood
Blood (2014) 124 (21): 1800.
https://doi.org/10.1182/blood.V124.21.1800.1800
Published: 2014
Journal Articles

Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML

Hadzijusufovic Emir, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD, PhD, Wilfried Schgoer, MD, PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, D.V.M., Gregor Hoermann, M.D., Ph.D., Wolfgang R Sperr, M.D., Rix Uwe, PhD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 257.
https://doi.org/10.1182/blood.V122.21.257.257
Published: 2013